Two Sigma Ventures’ Post

View organization page for Two Sigma Ventures, graphic

28,165 followers

Bringing a new drug to market takes over 10 years on average, with only 1 in 10 making it through the entire process. Fortunately, machine learning and AI are revolutionizing drug discovery and development, enabling faster delivery of more effective therapies. Last week, TSV Partner Dusan Perovic had the pleasure of diving into the impact of AI from bench to bedside with Julia Chou Chapin from Abridge and Robbie Freeman of Mount Sinai Health System. Thank you to Healthcare Brew and Patrick Kulp for giving us the floor to discuss everything from opportunity areas for startups and genAI to trust and safety at your Future of Health Tech event!

  • No alternative text description for this image
Peraya M.

Founder of LeadConnect: Connect Leads, Connect Success

1mo

Awesome content! Looking forward to your next post.

Like
Reply

To view or add a comment, sign in

Explore topics